SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005401
Filing Date
2015-11-13
Accepted
2015-11-13 12:05:41
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 536339
2 ex31-1.htm EX-31.1 18461
3 ex31-2.htm EX-31.2 18117
4 ex32-1.htm EX-32.1 7706
5 ex32-2.htm EX-32.2 6471
  Complete submission text file 0001493152-15-005401.txt   2444316

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20150930.xml EX-101.INS 344362
7 XBRL SCHEMA FILE prph-20150930.xsd EX-101.SCH 25938
8 XBRL CALCULATION FILE prph-20150930_cal.xml EX-101.CAL 36299
9 XBRL DEFINITION FILE prph-20150930_def.xml EX-101.DEF 78706
10 XBRL LABEL FILE prph-20150930_lab.xml EX-101.LAB 198631
11 XBRL PRESENTATION FILE prph-20150930_pre.xml EX-101.PRE 140176
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 151227866
SIC: 2834 Pharmaceutical Preparations